Abstract
There is a lack of effective means of promoting remyelination of the central nervous system (CNS) in humans with chronic demyelinating disease. We have investigated the ability of transplanted glia to myelinate areas of the CNS equivalent to focal demyelinated lesions in multiple sclerosis (MS). In these studies we show that transplantation of oligodendrocytes or their progenitors into the CNS of a neonatal or adult canine myelin mutant results in repair of large areas similar in size to many MS plaques. Progenitor or pre-progenitor cells of the oligodendrocyte lineage have the greatest capacity for myelination following grafting, although cells of neonatal origin may also be used. Such an approach may therefore have therapeutic value in the repair of focal lesions in human myelin disease.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Prineas, J.W., Barnard, R.O., Kwon, E.E., Sharer, L.R. & Cho, E.-S. Multiple sclerosis: Remyelination of nascent lesions. Ann. Neurol. 33, 137–151 (1993).
Prineas, J.W. et al. Multiple sclerosis: Pathology of recurrent lesions. Brain 116, 681–693 (1993).
Duncan, I.D. & Milward, E.A., Glial Cell transplants: Experimental therapies of myelin diseases. Brain Pathol. 5, 301–310 (1995).
Utzschneider, D.A., Archer, D.R., Kocsis, J.D., Waxman, S.G. & Duncan, I.D. Transplantation of glial cells enhances action potential conduction of amyelinated spinal cord axons in the myelin-deficient rat. Proc. Natl. Acad. Sci. USA 91, 53–57 (1994).
Honmou, O., Felts, P.A., Waxman, S.G. & Kocsis, J.D. Restoration of normal conduction properties in demyelinated spinal cord axons in the adult rat by transplantation of exogenous Schwann cells. J. Neurosci. 16, 3199–3208 (1996).
Lindvall, O. et al. Evidence for long-term survival and function of dopaminergic grafts in progressive Parkinson's disease. Ann. Neurol. 35, 172–180 (1994).
Freeman, T.B. et al. Bilateral fetal nigral transplantation into the postcommissural putamen in Parkinson's disease. Ann. Neurol. 38, 379–388 (1995).
Kordower, J.H. et al. Neuropathological evidence of graft survival and striatal rein-nervation after the transplantation of fetal mesencephalic tissue in a patient with Parkinson's disease. New Engl. J. Med. 332, 1118–1124 (1995).
Olanow, C.W., Kordower, J.H. & Freeman, T.B. Fetal nigral transplantation as a therapy for Parkinson's disease. Trends Neurosci. 19, 102–109 (1996).
Blakemore, W.F. & Crang, A.J. The effect of chemical injury on oligodendrocytes. in Viruses and Demyelinating Diseases, (eds. Cuzner, M. L. & Kelly, R. E.) 167–190 (Academic Press, London, 1983).
Nadon, N.L., Duncan, I.D. & Hudson, L.D. A point mutation in the proteolipid protein gene of the ‘shaking pup’ interrupts oligodendrocyte development. Development 110, 529–537 (1990).
Duncan, I.D. Inherited disorders of myelination of the central nervous system, in Neuroglial cells. (eds. Ransom, B.R. & Kettermann, H.R.) 990–1009 (Oxford Univ. Press, New York, 1995).
Duncan, I.D. & Hoffman, R.L. Spontaneous Schwann cell invasion of the CNS in the myelin mutants. J. Anat. (in the press).
Baron-Van Evercooren, A. et al. Cell–Cell interactions during the migration of myelin forming cells transplanted in the demyelinated spinal cord. Glia 16, 147–164 (1996).
Tontsch, U., Archer, D.R., Dubois-Dalcq, M. & Duncan, I.D. Transplantation of an oligodendrocyte cell line leading to extensive myelination. Proc. Natl. Acad. Sci. USA 91, 11616–11620 (1994).
Duncan, I.D., Paino, C., Archer, D.R. & Wood, P.M. Functional capacities of transplanted cell-sorted adult oligodendrocytes. Dev. Neurosci. 14, 114–122 (1992).
Warrington, A.E., Barbarese, E. & Pfeiffer, S.E. Differential myelinogenic capacity of specific developmental stages of the oligodendrocyte lineage upon transplantation into hypomyelinating hosts. J. Neurosci. Res. 34, 1–13 (1993).
Hammang, J.P., Reynolds, B.A., Weiss, S., Messing, A. & Duncan, I.D. Transplantation of epidermal growth factor-responsive neural stem cell progeny into murine central nervous system. Methods Neurosci. 21, 281–293 (1994).
Satoh, J. & Kim, S.U. Proliferation and differentiation of fetal human oligodendrocytes in culture. J. Neurosci. Res. 39, 260–272 (1994).
Seilhean, D., Gansmüller, A., Baron-Van Evercooren, A., Gumpel, M. & Lachapelle, F. Myelination by transplanted human and mouse central nervous system tissue after long-term cryopreservation. Acta Neuropathol. (Berl.) 91, 82–88 (1996).
Rosenbluth, J., Liu, Z., Guo, D. & Schiff, R. Myelin formation by mouse glia in myelin-deficient rats treated with cyclosporine. J. Neurocytol. 22, 967–977 (1993).
Archer, D.R., Leven, S. & Duncan, I.D. Myelination by cryopreserved xenografts and allografts in the myelin-deficient rat. Exp. Neurol. 125, 268–277 (1994).
Blakemore, W.F., Crang, A.J., Franklin, R.J.M., Tang, K. & Ryder, S., Glial cell transtransplants that are subsequently rejected can be used to influence regeneration of glial cell environments in the CNS. Glia 13, 79–91 (1995).
Li, D.W. & Duncan, I.D. The immune status of the myelin deficient rat and its immune responses to transplanted allogeneic glial cells. Soc. Neurosci. 20, 884 (1994).
Wood, M.J.A., Sloan, D.J., Wood, K.J. & Charlton, H.M. Indefinite survival of neural xenografts induced with anti-CD4 monoclonal antibodies. Neuroscience 70, 775–789 (1996).
Isacson, O. et al. Transplanted xenogeneic neural cells in neurodegenerative disease models exhibit remarkable axonal target specificity and distinct growth patterns of glial and axonal fibres. Nature Med. 1, 1189–1194 (1995).
Fabre, J.W. Nudging xenotransplantation towards humans. Nature Med. 1, 403–404 (1995).
Kidd, D. et al. Spinal cord MRI using multi-array coils and fast spin echo II: Findings in multiple sclerosis. Neurology 43, 2632–2637 (1993).
Compston, A. Future prospects for the management of multiple sclerosis. Ann. Neurol. 36, S146–S150 (1994).
Franklin, R.J.M. Reconstructing myelin-deficient environments in the CNS by glial cell transplantation. Neurosciences 5, 443–452 (1993).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Archer, D., Cuddon, P., Lipsitz, D. et al. Myelination of the canine central nervous system by glial cell transplantation: A model for repair of human myelin disease. Nat Med 3, 54–59 (1997). https://doi.org/10.1038/nm0197-54
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/nm0197-54
This article is cited by
-
N-Phenylquinazolin-2-amine Yhhu4952 as a novel promotor for oligodendrocyte differentiation and myelination
Scientific Reports (2018)
-
The remyelination Philosopher's Stone: stem and progenitor cell therapies for multiple sclerosis
Cell and Tissue Research (2012)
-
Transplantation of Placenta-Derived Mesenchymal Stem Cells in the EAE Mouse Model of MS
Journal of Molecular Neuroscience (2012)
-
Neural stem cells for spinal cord repair
Cell and Tissue Research (2012)
-
Cell Therapy for Multiple Sclerosis
Neurotherapeutics (2011)